Vaccination with two epitope peptides derived from LY6K (also named URLC10) and cell division associated 1 (CDCA1) induced specific CTLs (Cytotoxic T lymphocytes) expressing various TCRs in vaccinated lung cancer patients. Here, LY6K is linked to lung carcinoma.